The Center for Heart Failure Research (CHFR) was established in 2002 and has since then promoted the integration of high quality research from bench to bedside. Center members have a broad range of expertise, covering state-of-the-art gene technology, protein function, integrative physiology in pathophysiological models and clinical studies. This collective knowledge and active research collaboration has resulted in more than 200 scientific publications each year.
The Annual Symposiums that began in 2003 have constituted an important platform for networking, introduction of up-and-coming academic talents, along with impressive research results, not to mention the presence of important international speakers shedding light on recent advancements in cardiovascular research.
GE Vingmed Ultrasound together with Oslo University Hospital, University of Oslo, KU Leuven, University of Maastrich, Jessa Hospital in Belgium and Medaphor were recently awarded 1.6 million euros for a Marie Curie project that will utilize artificial intelligence to diagnose a number of heart disorders. Several of the international partners in the new project have previously been central to CCI's international research collaboration. Over the years, the network and the exchange of skills have been strengthened through joint workshops, studies presented at both national and international conferences and, not least, the exchange of students and professionals.
Several researchers presented their latest studies at the annual Congress of European Society for Cardiology, the largest get-together of its kind. Elevating the Congress further this year was its conjunction with the World Congress of Cardiology, putting the spotlight on global cardiovascular health, highlighting differences in prevalence, clinical manifestations, prevention strategies, diagnostic modalities and management of cardiovascular diseases around the world, as stated on the ESC webpage.
Due-Tønnessen N, Egeland CH, Meyerdierks OJ, Opdahl A(2021) Is radial artery occlusion and local vascular complications following transradial coronary procedures affected by the type of haemostasis device used? A non-inferiority Randomized Controlled Trial (RadCom trial) Eur J Cardiovasc Nurs(in press) DOI 10.1093/eurjcn/zvab004, PubMed 33615328
Brautaset Englund KV, Østby CM, Rolid K, Gude E, Andreassen AK, Gullestad L, Broch K(2021) Intravenous iron supplement for iron deficiency in cardiac transplant recipients (IronIC): A randomized clinical trial J Heart Lung Transplant(in press) DOI 10.1016/j.healun.2021.01.1390, PubMed 33612360
Storm BS, Halvorsen PS, Skulstad H, Dybwik K, Schjalm C, Christiansen D, Wisløff-Aase K, Fosse E, Braaten T, Nielsen EW, Mollnes TE(2021) Open chest and pericardium facilitate transpulmonary passage of venous air emboli Acta Anaesthesiol Scand(in press) DOI 10.1111/aas.13796, PubMed 33595102